Log in to search using one of your social media accounts:

This page shows you the most recent publications within this specialty of the MedWorm directory.

Knee Surgery Does Not Improve Life Quality for Many Patients Knee Surgery Does Not Improve Life Quality for Many Patients
Knee replacement surgery minimally improves quality of life for all but the most severely disabled, and is thus not cost-effective for less symptomatic patients.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - March 29, 2017 Category: Consumer Health News Tags: Rheumatology News Source Type: news

What is gout? YOU could be missing out on THIS treatment for painful condition
GOUT - a condition which people commonly associate with a rich diet - is a disorder which causes acute, intermittent and painful attacks of arthritis in the joints of the foot, knee, ankle, hand and wrist and especially the big toe. (Source: Daily Express - Health)
Source: Daily Express - Health - March 29, 2017 Category: Consumer Health News Source Type: news

Active Partners in Research
As companies increasingly integrate patient input into their R&D activities, they are coming to realize that they must also forge strong partnerships with patients and their families if they are to deliver truly patient-centered care. Yet, how do you transform buzzwords like patient engagement, patient voices, patient partnerships from theory into practice?It starts with being more systematic, says Danielle Gerlag, Patient Engagement Lead at  GlaxoSmithKline. “Over the last 10-15 years, we’ve done a lot to get the patient’s voice heard within GSK and there are pockets of excellence where we have engaged with pat...
Source: EyeForPharma - March 29, 2017 Category: Pharmaceuticals Authors: Deirdre Coleman Source Type: news

Knee Replacement Doesn't Always Pay: Researchers
Less pain to begin with, less gain from the procedure, but more benefit seen in those with severe arthritis (Source: WebMD Health)
Source: WebMD Health - March 29, 2017 Category: Consumer Health News Source Type: news

Xeljanz Approved for Rheumatoid Arthritis in European Union Xeljanz Approved for Rheumatoid Arthritis in European Union
Xeljanz has received marketing authorization from the European Commission for the treatment of patients with moderate-to-severe RA, providing a new oral treatment option for these patients.International Approvals (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - March 28, 2017 Category: Allergy & Immunology Tags: Rheumatology News Alert Source Type: news

Knee Replacement Doesn ' t Always Pay, Researchers Say
Less pain to begin with, less gain from the procedure, but more benefit seen in those with severe arthritis Source: HealthDay Related MedlinePlus Pages: Knee Injuries and Disorders, Knee Replacement (Source: MedlinePlus Health News)
Source: MedlinePlus Health News - March 28, 2017 Category: Consumer Health News Source Type: news

Moderate drinking 'does not risk liver damage for methotrexate users'
People receiving the common rheumatoidarthritis therapymethotrexate can safely drink moderate amounts of alcohol without running the risk of liver damage. This is according to a new study from the University of Manchester, funded by Arthritis Research UK, which shows that drinking 14 units of alcohol or fewer per week is not likely to cause any liver health issues. Sticking to modest levels of drinking'likely to be safe' Methotrexate is often taken over extended periods of time to limit or prevent joint damage and disability associated withrheumatoid arthritis. Generally, those receiving the drug are advised to abs...
Source: Arthritis Research UK - March 28, 2017 Category: Rheumatology Source Type: news

Patient Care & Rheumatology Network: Doc ' s Reflections on Patient Interactions
(MedPage Today) -- Also, two therapy types may work best for mucosal healing in IBD (Source: MedPage Today Public Health)
Source: MedPage Today Public Health - March 28, 2017 Category: American Health Source Type: news

Rheumatoid arthritis: Taking THIS drug with too much alcohol could be dangerous cocktail
RHEUMATOID arthritis sufferers taking particular medication are being warned not to drink too much alcohol - because they could be at increased risk of liver damage. (Source: Daily Express - Health)
Source: Daily Express - Health - March 28, 2017 Category: Consumer Health News Source Type: news

EC approves Pfizer's Xeljanz to treat rheumatoid arthritis in EU
The European Commission (EC) has approved Pfizer's Xeljanz (tofacitinib citrate) oral tablets to treat moderate-to-severe active rheumatoid arthritis (RA) in adult patients in the European Union (EU). (Source: Pharmaceutical Technology)
Source: Pharmaceutical Technology - March 27, 2017 Category: Pharmaceuticals Source Type: news

New study identifies targets for blocking cartilage breakdown in osteoarthritis
Scientists have made a potentially important discovery about the way that cartilage damage occurs in people withosteoarthritis, potentially opening the door for new treatments to be developed. Funded byArthritis Research UK and led by Oxford University's Kennedy Institute of Rheumatology, the study identified enzymes that play a key role in joint destruction, which could be targeted by future therapies.  How these molecules contribute to osteoarthritis Published in the medical journal Arthritis& Rheumatology, the research offers an important insight into how cartilage cells called chondrocytes are interrupted ...
Source: Arthritis Research UK - March 27, 2017 Category: Rheumatology Source Type: news

Arthritis Incidence Shifting Younger (CME/CE)
(MedPage Today) -- Generational disease prevalence may be tied to obesity (Source: MedPage Today Geriatrics)
Source: MedPage Today Geriatrics - March 27, 2017 Category: Geriatrics Source Type: news

ICER Report Claims RA Tx Is Not Cost Effective
(MedPage Today) -- Critics warn that conclusion could limit patient drug access (Source: MedPage Today Rheumatology)
Source: MedPage Today Rheumatology - March 27, 2017 Category: Rheumatology Source Type: news

Medical News Today: Arthritis mutilans: Symptoms, causes, and treatment
Arthritis mutilans is a rare form of inflammatory arthritis that causes severe inflammation and damage to bone tissue in the joints. Learn more. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - March 27, 2017 Category: Consumer Health News Tags: Arthritis / Rheumatology Source Type: news

All About Gout for Primary Care: Treating Chronic Disease
Preventing further acute attacks and decreasing the tophi burden becomes a secondary goal. (Source: ConsultantLive)
Source: ConsultantLive - March 27, 2017 Category: Internal Medicine Authors: Rebecca E. Sadun, MD, PhD Robert T. Keenan, MD, PhD Ryan C. Jessee, MD Tags: Special Report Gout Rheumatic Diseases Source Type: news

Travelling-wave ion mobility mass spectrometry elucidates structures of gold fingers
Drugs containing gold have been used for centuries to treat conditions like rheumatoid arthritis. In addition, they might be effective against cancer and HIV. One mechanism by which they work could occur because gold ions force the zinc ions out of zinc fingers -- looped, nucleic acid binding protein domains. American researchers have characterized such ' gold fingers ' using ion mobility mass spectrometry. They identified the exact gold binding sites. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - March 27, 2017 Category: Science Source Type: news

Gout Rounds: 5 New Developments
Primary care can do more to help reduce gout morbidity, says a new review —plus 4 more studies on gout treatment and prevention. (Source: ConsultantLive)
Source: ConsultantLive - March 27, 2017 Category: Internal Medicine Authors: Leo Robert Tags: Cardiovascular Diseases Special Report Gout Rheumatic Diseases Source Type: news

XELJANZ ® (tofacitinib citrate) receives marketing authorisation in the European Union for the treatment of moderate to severe active rheumatoid arthritis
Pfizer Inc. (NYSE:PFE) announced today that the European Commission (EC) has approved XELJANZ® (tofacitinib citrate) 5 mg twice daily (BID) oral tablets in combination with methotrexate (MTX) for the treatment of moderate to severe active rheumatoid arthritis (RA) in adult patients who have responded inadequately to, or who are intolerant to one or more disease-modifying antirheumatic drugs (DMARDs). (Source: World Pharma News)
Source: World Pharma News - March 27, 2017 Category: Pharmaceuticals Tags: Featured Pfizer Business and Industry Source Type: news

Mobile gold fingers
(Wiley) Drugs containing gold have been used for centuries to treat conditions like rheumatoid arthritis. In addition, they might be effective against cancer and HIV. One mechanism by which they work could occur because gold ions force the zinc ions out of zinc fingers -- looped, nucleic acid binding protein domains. American researchers have characterized such 'gold fingers' using ion mobility mass spectrometry. As reported in the journal Angewandte Chemie, they identified the exact gold binding sites. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - March 27, 2017 Category: Global & Universal Source Type: news

Second degree burn to mustard powder - Tartar DM, Sharon VR.
Mustard seeds and powder are commonly used in homeopathic and traditional medicines, in which they are believed to have both anti-microbial andanti-inflammatory properties. They are therefore utilized in the treatment of conditions ranging from arthritis t... (Source: SafetyLit)
Source: SafetyLit - March 25, 2017 Category: Global & Universal Tags: Alcohol and Other Drugs Source Type: news

Modified protein promotes hair growth and fights ageing in mice
Conclusion This mouse study aimed to investigate whether there are ways to target and destroy senescent cells that have stopped dividing yet somehow avoid the normal cell-death pathways. Removing these cells could counteract damage to tissue in the body caused by medical treatments such as chemotherapy, and accelerated or natural ageing. It essentially found that a modified peptide (FOXO4-DRI) was able to cause death of the senescent cells. In turn, this was able to counteract the liver and kidney cell toxicity induced by a chemotherapy drug, in addition to reducing frailty and loss of fur density in the mice. Animal studi...
Source: NHS News Feed - March 24, 2017 Category: Consumer Health News Tags: Medication Source Type: news

Clinical Trials of Biosimilars Should Become More Similar Clinical Trials of Biosimilars Should Become More Similar
Clinical trials of biosimilars to treat inflammatory diseases may not be so similar. Why aren ' t trial designs more standardized?Annals of the Rheumatic Diseases (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - March 24, 2017 Category: Consumer Health News Tags: Rheumatology Journal Article Source Type: news

How to Boost Your Stem Cells
A California man named Kris Boesen was completely paralyzed after breaking his neck in a terrible car crash last March. But now he can brush his teeth and hug his family again… He's even started to regain sensation in his legs. And it's all because of a simple procedure he underwent about a month after his accident: stem cell therapy. During Kris' procedure, researchers at the University of Southern California injected 10 million stem cells into his spinal cord. Within two weeks, he could wiggle his fingers. Three months later, he was able to feed himself, write his name and operate his wheelchair. His re...
Source: Al Sears, MD Natural Remedies - March 23, 2017 Category: Complementary Medicine Authors: Al Sears Tags: Anti-Aging Source Type: news

European Commission Approves AMGEVITA ™ (Biosimilar Adalimumab) For The Treatment Of Certain Inflammatory Diseases
First Biosimilar Adalimumab Approved in the European Union THOUSAND OAKS, Calif., March 23, 2017 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced that the European Commission (EC) has granted marketing authorization for AMGEVITA™ (biosimilar adalimumab1) in all available indications. AMGEVITA is authorized for the treatment of certain inflammatory diseases in adults, including moderate-to-severe rheumatoid arthritis; psoriatic arthritis; severe active ankylosing spondylitis (AS); severe axial spondyloarthritis without radiographic evidence of AS; moderate-to-severe chronic plaque psoriasis; moderate-to-severe hi...
Source: Amgen News Release - March 23, 2017 Category: Pharmaceuticals Tags: Uncategorized Source Type: news

U.S. Appeals Court Revives Fosamax Warning Claims Against Merck U.S. Appeals Court Revives Fosamax Warning Claims Against Merck
A federal appeals court on Wednesday revived hundreds of claims by plaintiffs who accused Merck& Co of failing to adequately warn about the risks of thigh bone fractures associated with its osteoporosis drug Fosamax (alendronate).Reuters Health Information (Source: Medscape Orthopaedics Headlines)
Source: Medscape Orthopaedics Headlines - March 23, 2017 Category: Orthopaedics Tags: Rheumatology News Source Type: news

Chlorofields Recalls Asian MIicrogreens Because Of Possible Health Risk
ChloroFields of Lawrence, KS is recalling 20 cases of Asian Microgreens, because they have potential to be contaminated with Salmonella, an organism which can cause serious and sometimes fatal infections in young children, frail or elderly people, and others with weakened immune systems. Healthy persons infected with Salmonella often experience fever, diarrhea, nausea, vomiting, and abdominal pain. In rare circumstances, infection with Salmonella can result in the organism getting into the bloodstream and producing more severe illnesses such as arterial infections (i.e., infected aneurysms), endocarditis and arthr...
Source: Food and Drug Administration - March 23, 2017 Category: Food Science Source Type: news

New tool to treat rheumatoid arthritis discovered
A Swedish study suggests antibodies against the cartilage protein collagen II could aid in predicting prognosis and therapy choice for rheumatoid arthritis. (Source: Health News - UPI.com)
Source: Health News - UPI.com - March 23, 2017 Category: Consumer Health News Source Type: news

Clinical Nurse Specialist in Endocrinology - University Hospitals Birmingham NHS Foundation Trust
Job reference: 304-A-17-32566Salary:£26,302 -£35,225This excellent opportunity is open to experienced registered nurses with at least 5 years’ experience in acute care setting. Candidates with experience in endocrinology are highly encouraged to consider this post.The successful candidate will join a team of experienced specialist nurses in a tertiary Endocrine referral centre and will be given full structured training and supervision to develop his/her skills in Endocrinology.The department has close links with the University of Birmingham, Birmingham Children’s Hospital and Birming...
Source: Society for Endocrinology - March 23, 2017 Category: Endocrinology Source Type: news

New tool for prognosis and choice of therapy for rheumatoid arthritis
(Uppsala University) In rheumatoid arthritis, antibodies are formed that affect the inflammation in the joints. In an article published today in the journal Annals of the Rheumatic Diseases, researchers at Uppsala University show that antibodies against the cartilage protein collagen II are associated with a good prognosis. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - March 23, 2017 Category: Global & Universal Source Type: news

New biomarker 'could aid prediction of rheumatoid arthritis outcomes'
A new biomarker has been discovered that could make it easier to predict which rheumatoidarthritis patients are most likely to experience a positive prognosis. Researchers at Uppsala University have carried out a study showing that antibodies against the cartilage protein collagen II are associated with better outcomes, and could be helpful in determining the best treatment to use for each patient. A link between collagen antibodies and disease development For this study, a large group ofrheumatoid arthritis patients were followed over five years to establish a possible correlation between collagen antibody levels and dise...
Source: Arthritis Research UK - March 23, 2017 Category: Rheumatology Source Type: news

Providing physical activity interventions for people with musculoskeletal conditions report
Arthritis Research UK has published a report to help local authorities and commissioners to ensure that local physical activity provision meets the needs of people with musculoskeletal conditions. (Source: NHS Networks)
Source: NHS Networks - March 23, 2017 Category: UK Health Source Type: news

New Treatment Relieves Knee Pain Without Surgery
BOSTON (CBS) – Americans of all ages suffer from knee pain and stiffness due to cartilage loss. However, a recent FDA approved treatment might bring relief to patients and it is being performed in Boston. Dr. Mallika Marshall introduces us to Chris, the first patient to undergo the procedure. Chris suffers from a rare condition called Osteochondritis dissecans, which causes cartilage in his joints to break down. Chris, who prefers not to use his last name, dealt with knee problems for most of his life, including unbearable pain in his left knee. “It was quite painful, sports were difficult, and then walking beca...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - March 21, 2017 Category: Consumer Health News Authors: Health – CBS Boston Tags: Health Local News Syndicated Local Boston Brigham and Women's Hospital Dr. Mallika Marshall Knee Treatment Maci Osteochondritis dissecans Source Type: news

New Treatment Relieves Knee Pain Without Replacement Surgery
BOSTON (CBS) – Americans of all ages suffer from knee pain and stiffness due to cartilage loss. However, a recent FDA approved treatment might bring relief to patients and it is being performed in Boston. Dr. Mallika Marshall introduces us to Chris, the first patient to undergo the procedure. Chris suffers from a rare condition called Osteochondritis dissecans, which causes cartilage in his joints to break down. Chris, who prefers not to use his last name, dealt with knee problems for most of his life, including unbearable pain in his left knee. “It was quite painful, sports were difficult, and then walking became ...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - March 21, 2017 Category: Consumer Health News Authors: Health – CBS Boston Tags: Health Local News Syndicated Local Boston Brigham and Women's Hospital Dr. Mallika Marshall Knee Treatment Maci Osteochondritis dissecans Source Type: news

All About Gout for Primary Care: Treating Acute Gout
The faster the attack is recognized and treated with medications, the easier it is to control. (Source: ConsultantLive)
Source: ConsultantLive - March 21, 2017 Category: Internal Medicine Authors: Rebecca E. Sadun, MD, PhD Robert T. Keenan, MD, MPH Ryan C. Jessee, MD Tags: Special Report Gout Rheumatic Diseases Source Type: news

All About Gout for Primary Care: The Diagnosis
Clinical presentation, history, and laboratory evaluation can make a diagnosis of gout, but crystal examination is the “gold standard.” (Source: ConsultantLive)
Source: ConsultantLive - March 21, 2017 Category: Internal Medicine Authors: Rebecca E. Sadun, MD, PhD Robert T. Keenan, MD, MPH Ryan C. Jessee, MD Tags: Special Report Gout Rheumatic Diseases Source Type: news

Single Intradiscal Steroid Shot Provides Short Relief Single Intradiscal Steroid Shot Provides Short Relief
A randomized controlled trial showed no difference in back pain intensity at 12 months between patients who received injections and those who did not.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - March 21, 2017 Category: Consumer Health News Tags: Rheumatology News Source Type: news

New Enterprise Associates gets in on SetPoint Medical
SetPoint Medical said today that it has received an investment from venture capital firm New Enterprise Associates. SetPoint is developing a neuromodulation device designed to stimulate the vagus nerve to trigger the body’s anti-inflammatory response, according to the company. Newly vested NEA joins existing investors Medtronic (NYSE:MDT), Boston Scientific (NYSE:BSX), GlaxoSmithKline‘s (NYSE:GSK) Action Potential Venture Capital Limited, Morgenthaler Ventures and Topspin Partners. “We are proud that SetPoint has attracted such a prestigious and experienced investor. NEA is known for its support of companies...
Source: Mass Device - March 20, 2017 Category: Medical Equipment Authors: Fink Densford Tags: Business/Financial News Neuromodulation/Neurostimulation SetPoint Medical Source Type: news

UCB works with Garmin on wellness program for rheumatoid arthritis patients
Global pharmaceutical company UCB has launched Wellness4U, a health and wellness platform for  people living with immunologic disorders which includes, as one aspect, an activity tracker pilot program. (Source: mobihealthnews)
Source: mobihealthnews - March 20, 2017 Category: Information Technology Source Type: news

All About Gout for Primary Care
How to regulate “the king of diseases and the disease of kings” is this Patient Care Special Report ' s domain. (Source: ConsultantLive)
Source: ConsultantLive - March 20, 2017 Category: Internal Medicine Authors: Rebecca E. Sadun, MD, PhD Robert T. Keenan, MD, MPH Ryan C. Jessee, MD Tags: Gout Rheumatic Diseases Source Type: news

Make the Diagnosis: Manual Mystery
(MedPage Today) -- Case Findings: A 77-year-old male who is left-hand-dominant presents with a loss of dexterity and limited extension of the fingers of his left hand. He mentions that his ability to play the piano has decreased over the past few months. On examination, he has skin dimpling on the palm of his left hand, and he is unable to lay it flat on the table. What is your diagnosis (Source: MedPage Today Rheumatology)
Source: MedPage Today Rheumatology - March 20, 2017 Category: Rheumatology Source Type: news

Biologic-Naive PsA Patients Persist on Therapy (CME/CE)
(MedPage Today) -- Pattern similar to what is seen in rheumatoid arthritis (Source: MedPage Today Dermatology)
Source: MedPage Today Dermatology - March 19, 2017 Category: Dermatology Source Type: news

Examining the relationship between pain catastrophizing and suicide risk in patients with rheumatic disease: the mediating role of depression, perceived social support, and perceived burdensomeness - Shim E-, Song YW, Park SH, Lee KM, Go DJ, Hahm BJ.
This study examines whether depression, perceived social support (PSS), and pe... (Source: SafetyLit)
Source: SafetyLit - March 18, 2017 Category: Global & Universal Tags: Ergonomics, Human Factors, Anthropometrics, Physiology Source Type: news

Study Examines Characteristics of Psoriatic Spondyloarthritis in Psoriatic Arthritis With Ankylosing Spondylitis
No abstract available (Source: Lippincott's Bone and Joint Newsletter)
Source: Lippincott's Bone and Joint Newsletter - March 18, 2017 Category: Orthopaedics Tags: CME Article Source Type: news

Major Unanswered Questions in the Clinical Gout Field Major Unanswered Questions in the Clinical Gout Field
Advancing research has contributed to the understanding of gout and the development of new therapies, but certain questions remain.Current Opinion in Rheumatology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - March 17, 2017 Category: Consumer Health News Tags: Rheumatology Journal Article Source Type: news

Checkpoint Therapy: Good for Cancer, Bad for Rheumatology Checkpoint Therapy: Good for Cancer, Bad for Rheumatology
Checkpoint therapy has shown success in the treatment of cancer, but may also contribute to the development of rheumatic conditions.Annals of the Rheumatic Diseases (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - March 17, 2017 Category: Consumer Health News Tags: Rheumatology Journal Article Source Type: news

Oxford BioDynamics joins collaboration to identify biological factors that cause RA flares
UK-based biotechnology company Oxford BioDynamics has participated in a collaboration to identify biological factors that cause disease relapses, known as flares, in patients with rheumatoid arthritis (RA). (Source: Pharmaceutical Technology)
Source: Pharmaceutical Technology - March 17, 2017 Category: Pharmaceuticals Source Type: news

Modified red blood cells 'could alleviate autoimmune diseases'
This study is interesting and has the potential to be a tool used to both treat and prevent rheumatoid arthritis. It is promising to see that autoimmunity could be treated in mice, but people with arthritis need to be aware that this research is in its very early stages. "More research is needed to determine how the results can be translated into a benefit for people living inpain now, and for those who may develop arthritis in the future." (Source: Arthritis Research UK)
Source: Arthritis Research UK - March 17, 2017 Category: Rheumatology Source Type: news

Patrick Stewart Reveals He Uses Marijuana Daily To Help With Arthritis Symptoms
function onPlayerReadyVidible(e){'undefined'!=typeof HPTrack&&HPTrack.Vid.Vidible_track(e)}!function(e,i){if(e.vdb_Player){if('object'==typeof commercial_video){var a='',o='m.fwsitesection='+commercial_video.site_and_category;if(a+=o,commercial_video['package']){var c='&m.fwkeyvalues=sponsorship%3D'+commercial_video['package'];a+=c}e.setAttribute('vdb_params',a)}i(e.vdb_Player)}else{var t=arguments.callee;setTimeout(function(){t(e,i)},0)}}(document.getElementById('vidible_1'),onPlayerReadyVidible); Sir Patrick Stewart has opened up about his struggle with arthritis and how he turns to marijuana on a daily basis to comb...
Source: Healthy Living - The Huffington Post - March 16, 2017 Category: Consumer Health News Source Type: news